Skip to content

Estradiol and Testosterone Levels in Seminal Plasma of Men With Non-obstructive Azoospermia

Are Estradiol and Testosterone Levels in Seminal Plasma Predictive for Efficient Spermatogenesis in Men With Non- Obstructive Azoospermia

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02255396
Enrollment
50
Registered
2014-10-02
Start date
2009-01-31
Completion date
2014-06-30
Last updated
2014-10-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non-obstructive Azoospermia With Testicular Biopsy for Spermatozoa Extraction

Brief summary

Estradiol and Testosterone are two important hormones for the regulation of an effective spermatogenesis in human testis. The evaluation of levels of estradiol and testosterone in seminal plasma of men with non-obstructive azoospermia may be a predictive test before surgical testicular biopsy to determine the chance of a positive sperm extraction to use for ICSI.

Detailed description

The aim of this study is to compare the levels of esttradiol and testosterone in seminal plasma of men with non-obstructive azoospermia. Indeed, for these patients, none biological test allows to predict a positive sperm extraction before the surgical testis biopsy is performed. Since the involvement of estradiol and testosterone in the regulation of spermatogenesis, the measurement of these hormones in seminal plasma may be a predictive tool for these men before testis biopsy.

Interventions

OTHERESTRADIOL

Sponsors

University Hospital, Clermont-Ferrand
Lead SponsorOTHER

Study design

Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
MALE
Age
18 Years to 55 Years
Healthy volunteers
No

Inclusion criteria

* Azoospermia confirmed by two semen analysis (at minimum 74 days between the both analysis) * Volume of seminal plasma \>0.6ml * Testicular biopsy one month after the last semen analysis * Informed consent signed by the patient

Exclusion criteria

* obstructive azoospermia * cryptozoospermia

Design outcomes

Primary

MeasureTime frame
Levels of estradiol and testosterone in seminal plasma of men with non-obstuctive azoospermiaat 1 month
Issue of testicular biopsy (sperm extraction positive or negative)at day 1

Secondary

MeasureTime frame
Degrees of alteration of testis histologyat day 1
Serum levels of estradiol and testosteroneat day 1

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026